ABSTRACT
During the past decade USA, Canada, Europe and Australia have each witnessed increasing trends in the use of illicitly produced drugs and substantial increases in the scale and diversity of illicit drug manufacturing laboratories. New Zealand has also experienced a considerable increase in illicit drug manufacture, with emphasis on ‘home-bake’ heroin (Bedford and Nolan, 1992), Cannabis L extracts (and products) and more recently amphetamines (Norris, 1995; Coxon, 1997-present).
